Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.23B
Enterprise Value3.03B
P/E Ratio22.95
PEG Ratio0.89
Price/Sales Ratio4.97
Price/Book Ratio2.12
Enterprise/Revenue4.86
Enterprise/EBITDA16.9

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.22
Operating Margin0.26
AD

Management Effectiveness

Return On Assets0.08
Return On Equity0.1

Income Statement

Revenue1.04B
Revenue/Share2.05
Gross Profit803.62M
EBITDA281M
Net Income198.12M
Diluted EPS0.39

Balance Sheet

Total Cash570.93M
Total Cash/Share1.13
Total Debt50.98M
Total Debt/Equity0.02
Current Ratio4.8
Book Value Per Share4.81

Price History

52-Week Change46.2
52-Week High10.19
52-Week Low5.32
Moving Average 50 Days6.67
Moving Average 200 Days6.81

Statistics

Average Volume23.85M
Shares Outstanding503.2M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield2.94
Payout Ratio0.01
Last Split Factor17:10
Last Split DateMay 30, 2019
AD